Effective July 1, 2021, AmeriHealth will make changes to its Select Drug Program® Formulary and Value Formulary, including:
- Generic additions
- Prior authorization
- Morphine milligram equivalent, age, and quantity limits
- Non-preferred brand
Albuterol HFA aerosol
Effective July 1, 2021, Albuterol HFA aerosol (authorized generic of Ventolin® HFA brand only) will require a prior authorization, including documentation of inadequate response or inability to tolerate the brand version, Proair® HFA aerosol. It will also have a quantity limit of two inhalers per 30 days. Albuterol HFA aerosol will be considered non-preferred on the Select Drug Program and Value formulary.
Albuterol HFA inhalers are indicated for the treatment or prevention of bronchospasm in patients with reversible obstructive airway disease, including asthma and chronic obstructive pulmonary disease (COPD).
Note: Generic albuterol (brand ProAir® and Proventil®) is covered under the generic cost-share tier on the Select Drug Program formulary and Value formulary.
Learn more
Review the changes that go into effect July 1, 2021:
-
AmeriHealth New Jersey:
-
AmeriHealth Pennsylvania:
To view Select Drug Formulary information for your patients who carry an AmeriHealth Administrators ID card, visit the AmeriHealth Administrators
website.
For more on pharmacy policies and programs, visit our websites for
AmeriHealth New Jersey or
AmeriHealth Pennsylvania.